The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.35
Bid: 8.00
Ask: 8.70
Change: 0.20 (2.45%)
Spread: 0.70 (8.75%)
Open: 8.25
High: 8.35
Low: 8.25
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new Auditor

11 Nov 2021 07:00

RNS Number : 0158S
Tekcapital plc
11 November 2021
 

 

 

 

11 November 2021

Tekcapital Plc

("Tekcapital", the "Company" or the "Group")

Appointment of New Auditor

 

Tekcapital Plc (AIM: TEK, OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people's lives, is pleased to announce that following a competitive tender process, overseen by the Audit Committee, the Board has appointed MacIntyre Hudson LLP ("MacIntyre Hudson"), the UK member of Baker Tilly International, as the Company's and Group's auditor with immediate effect.

 

Tekcapital CFO, Konrad Dabrowski, commented: "We are pleased to appoint MacIntyre Hudson as our auditor. Their size, international presence and industry experience aligns with the Group's on-going cross-border expansion."

 

The Board of Tekcapital looks forward to working with MacIntyre Hudson and Baker Tilly International, one of the world's leading accounting networks.

 

We would like to thank HW Fisher for the excellent and professional services they have provided to the Company over the past six years.

 

 

For further information, please contact:

 

Tekcapital Plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)

Richard Parlons / Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

Forward-Looking Statements

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Tekcapital does not intends nor assume any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBMBLTMTJBBFB
Date   Source Headline
26th Jan 20177:00 amRNSProposed placing
12th Jan 20177:00 amRNSNotice of Allowance for Energy Harvester Patent
4th Jan 20177:00 amRNSSuccessful Production and Testing of µSaltTM
28th Dec 20167:00 amRNSOut-licence & Strategic Alliance with Wecast
9th Nov 20167:00 amRNSDirectorate Change
31st Oct 20167:00 amRNSStrategic Alliance with Bajainnova SAPI de CV
28th Oct 20167:00 amRNSNotice of Allowance for 2nd Crackle-baked Patent
25th Oct 20167:00 amRNSPrivate Placement for Belluscura Ltd
7th Oct 20164:28 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSAcquisition of Medical Device Licence
31st Aug 20167:00 amRNSHalf-year Report
30th Jun 20167:30 amRNSGrant of Options
17th Jun 20167:00 amRNSPrivate Placement for Belluscura Ltd
6th Jun 201611:44 amRNSAcquisition of salt reduction technology patent
27th May 20162:47 pmRNSResult of AGM
4th May 20167:00 amRNSPosting of Annual Report and Notice of AGM
29th Apr 20167:00 amRNSFinal Results
28th Apr 20167:00 amRNSAcquisition and Total Voting Rights
20th Apr 201612:53 pmRNSHolding(s) in Company
13th Apr 20167:00 amRNSAcquisition of Medical Devices
14th Mar 20167:00 amRNSNew Technology License
12th Feb 20167:00 amRNSDirectorate Change
12th Jan 20167:00 amRNSTekcapital Chairman announced as award finalist
4th Jan 20163:06 pmRNSHolding(s) in Company
24th Dec 20157:00 amRNSAcquisition of Energy Harvesting Technology
22nd Dec 201512:52 pmRNSHolding(s) in Company
30th Nov 20155:30 pmRNSTotal Voting Rights
24th Nov 20152:14 pmRNSExercise of warrants and total voting rights
23rd Nov 20157:00 amRNSPatent Update for Crackle-baked(R) Technology
13th Nov 20159:15 amRNSHolding(s) in Company
10th Nov 20157:00 amRNSDirectorate Change
9th Nov 20157:00 amRNSNew Patent Application
9th Oct 20157:00 amRNSHolding(s) in Company
28th Aug 20155:00 pmRNSTotal Voting Rights
20th Aug 20157:00 amRNSHalf Yearly Report
14th Aug 20157:00 amRNSAcquisition of air conditioning efficiency patents
29th Jun 20157:00 amRNSAcquisition of energy harvesting technologies
22nd Jun 20154:27 pmRNSHolding(s) in Company
12th Jun 201511:52 amRNSResult of General Meeting
8th Jun 20157:00 amRNSGrant of Share Options
29th May 20156:15 pmRNSHolding(s) in Company
29th May 20156:15 pmRNSTotal Voting Rights
29th May 20151:13 pmRNSResult of AGM
21st May 201512:52 pmRNSFinal Results
14th May 20154:07 pmRNSHolding(s) in Company
13th May 20157:00 amRNSHolding(s) in Company
12th May 20152:00 pmRNSHolding(s) in Company
12th May 20157:00 amRNSHolding in Company and Directorate Change
6th May 20152:46 pmRNSNotice of AGM
6th May 20157:01 amRNSPlacing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.